Flamma Capabilities Update October 2026: Small Molecule Drug Substance

API and peptide development is evolving beyond traditional batch chemistry as manufacturers look for faster, more controlled and efficient ways to move processes toward scale. Flow chemistry, laboratory automation and data-driven experimentation offer new opportunities to improve process understanding, repeatability and technology transfer.

Emerging approaches such as liquid-phase peptide synthesis and mechanochemistry could further expand the options available for complex molecules, particularly when conventional methods create challenges with solvent use, productivity or scalability. Connecting these capabilities with real-time analytics and machine learning may also enable development teams to evaluate conditions and optimize processes more efficiently while keeping scientists in control of development strategy.

Watch the webinar to explore how these technologies are being applied and what they could mean for the future of API and peptide development.